Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity
Radiation survival curves were generated for V79 Chinese hamster and two human lung cancer cell lines (NCI-H460 and NCI-H249) with doubling times of 10, 20, and 85 h, respectively, using a standard clonogenic assay, a dye exclusion assay, and a semiautomated colorimetric assay utilizing a tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylformazan bromide. Comparable results for D0 and extrapolation number (n) were observed for all assays in the lines with doubling times of 10 and 20 h. In these instances the tumor cell lines had undergone seven or more doublings after radiation. For the tumor line (H249) with an 80-h doubling time the D0S were comparable between the assays while the extrapolation number was increased in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylformazan bromide assay, a result probably related to the lower number of doublings (less than 4) after radiation. We then tested the ability of the assays to detect radiation protection and sensitization using known agents. We found that cysteamine treatment resulted in radioprotection (by a factor of 8 at 8 Gy) while 5-bromo-2-deoxyuridine incorporation caused enhancement of radiation sensitivity in all three assays. We conclude that, while optimal conditions for each cell line (cell number plated and doubling time) must be established, using characterized tumor cell lines, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylformazan bromide assay could be automated and thus be of great value in screening large numbers of potential radiosensitizers or protectors.
- Research Organization:
- NCI-Navy Medical Oncology Branch, Bethesda, MD
- OSTI ID:
- 6646545
- Journal Information:
- Cancer Res.; (United States), Vol. 4
- Country of Publication:
- United States
- Language:
- English
Similar Records
MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA
Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay
Related Subjects
ANIMAL CELLS
RADIOSENSITIVITY
BUDR
RADIOSENSITIVITY EFFECTS
MEA
TUMOR CELLS
BIOASSAY
CLONE CELLS
DYES
SURVIVAL CURVES
THIAZOLES
AMINES
ANTIMETABOLITES
AZINES
AZOLES
BROMOURACILS
CELL CULTURES
DRUGS
HETEROCYCLIC COMPOUNDS
HYDROXY COMPOUNDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC BROMINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANIC SULFUR COMPOUNDS
PYRIMIDINES
RADIOPROTECTIVE SUBSTANCES
RIBOSIDES
THIOLS
URACILS
560120* - Radiation Effects on Biochemicals
Cells
& Tissue Culture